Fact check · Version 1 · Sources checked

“LL-37 is proven to heal wounds in people.”

The Peptide Field explains research. Its pages are not independently medically reviewed, and they do not diagnose, prescribe, or recommend treatment.

Not established

The reviewed evidence does not establish this statement. This does not prove it can never be true.

The first 34-person leg-ulcer study reported possible benefit. A later study assigned 149 people to LL-37 or placebo. Of those people, 148 received a study treatment. It found no clear benefit for the full group. A 25-person diabetic-foot-ulcer study found a limited sign of new tissue growth, but no clear changes in other measures. These results do not prove general wound healing.

What this answer is based on
This answer uses a study that assigned people to groups by chance and measured a health outcome.
Limits of this answer
The reviewed venous-ulcer studies and small diabetic-foot-ulcer study; results apply only to their defined products, groups, wound types, and follow-up periods. These limits show which substance, product, people, use, place, and time the answer covers. A different product or situation can have a different answer.
Topic
What a study measured about people's health, symptoms, or ability to function.

Sources for this fact check

Show 3 sources
Sources checked by
Site editor · Editorial review

More about LL-37

See the FDA and sports-rule status of LL-37

Other fact checks on LL-37